Hepion Pharmaceuticals Stock Forecast

Sell candidate since Jun 08, 2026 Loss -8.36%

No changes to the price of Hepion Pharmaceuticals, Inc. stock on the last trading day (Thursday, 11th Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0559 to a day high of $0.0559. The price has fallen in 6 of the last 10 days and is down by -20.14% for this period.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0470 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 37.56% during the next 3 months and, with a 90% probability hold a price between $0.0646 and $0.138 at the end of this 3-month period.

HEPA Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Hepion Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0623 and $0.0663. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Hepion Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0521 and $0.0505. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Hepion Pharmaceuticals, Inc. finds support just below today's level at $0.0521. If this is broken, then the next support from accumulated volume will be at $0.0505 and $0.0454.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 17.06%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HEPA) For The Upcoming Trading Day Of Friday 12th

For the upcoming trading day on Friday, 12th we expect Hepion Pharmaceuticals, Inc. to open at $0.0559, and during the day (based on 14 day Average True Range), to move between $0.0502 and $0.0616, which gives a possible trading interval of +/-$0.0114 (+/-22.72%) up or down from last closing price. If Hepion Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 22.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0570 (1.97%) than the support at $0.0521 (6.89%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Hepion Pharmaceuticals, Inc. stock A Buy?

The Hepion Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Hepion Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.665 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 12, 2026 - $0.0559 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk